• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Adverse events in bevacizumab and chemotherapy: patient management.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Blowers, Elaine
    Hall, Kate
    Affiliation
    Christie Hospital NHS Foundation Trust, Manchester.
    Issue Date
    2009-02
    
    Metadata
    Show full item record
    Abstract
    Bevacizumab (Avastin) is an anti-angiogenic agent recently approved for the treatment of metastatic breast cancer in combination with paclitaxel. It is important that nurses are familiar with the side-effects associated with this agent--several of which differ from those seen with traditional chemotherapy agents--and how these can be optimally identified, monitored and managed. Side-effects associated with bevacizumab include hypertension, proteinuria, thromboembolic events, bleeding, cardiac toxicity, wound-healing complications and gastrointestinal perforations. Many of these are easily manageable, often without the need to discontinue bevacizumab therapy. This article, the second in a series, provides nurses with management recommendations for these toxicities in order to deliver optimal patient care and improve patients quality of life.
    Citation
    Adverse events in bevacizumab and chemotherapy: patient management., 18 (7):424-8 Br J Nurs
    Journal
    British Journal of Nursing
    URI
    http://hdl.handle.net/10541/69598
    PubMed ID
    19373187
    Type
    Article
    Language
    en
    ISSN
    0966-0461
    Collections
    All Christie Publications
    Medical Oncology

    entitlement

    Related articles

    • Managing adverse events in the use of bevacizumab and chemotherapy.
    • Authors: Blowers E, Hall K
    • Issue date: 2009 Mar 26-Apr 8
    • Managing patients treated with bevacizumab combination therapy.
    • Authors: Gordon MS, Cunningham D
    • Issue date: 2005
    • Safety of bevacizumab in patients with metastatic breast cancer.
    • Authors: Hamilton EP, Blackwell KL
    • Issue date: 2011
    • Intricacies of bevacizumab-induced toxicities and their management.
    • Authors: Gressett SM, Shah SR
    • Issue date: 2009 Mar
    • Managing patients with metastatic colorectal cancer on bevacizumab.
    • Authors: Lemmens L, Claes V, Uzzell M
    • Issue date: 2008 Aug 14-Sep 10
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.